Inventiva (NASDAQ:IVA - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They presently have a $13.00 price objective on the stock. HC Wainwright's price objective points to a potential upside of 344.44% from the company's previous close.
Separately, TD Cowen assumed coverage on Inventiva in a research report on Friday, February 21st. They issued a "buy" rating and a $10.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Inventiva has an average rating of "Moderate Buy" and an average price target of $12.60.
View Our Latest Research Report on Inventiva
Inventiva Stock Performance
Shares of IVA traded down $0.02 during mid-day trading on Friday, reaching $2.93. The stock had a trading volume of 18,946 shares, compared to its average volume of 62,419. The business has a fifty day moving average of $2.72 and a 200 day moving average of $2.49. Inventiva has a 12 month low of $1.53 and a 12 month high of $3.98.
About Inventiva
(
Get Free Report)
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.
Further Reading
Before you consider Inventiva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inventiva wasn't on the list.
While Inventiva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
